There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Globus Medical (GMED – Research Report) and ...

In a report released today, Matt Miksic from Barclays maintained a Buy rating on Globus Medical (GMED – Research Report), with a price target ...

Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced preliminary unaudited sales results for the ...

Globus Medical (NYSE:GMED – Free Report) had its target price increased by Canaccord Genuity Group from $92.00 to $101.00 in ...

Needham & Company LLC reissued their hold rating on shares of Globus Medical (NYSE:GMED – Free Report) in a research note published on Thursday,Benzinga reports. Several other brokerages have also ...

BofA Securities has upgraded Globus Medical (NYSE:GMED) to neutral from underperform, citing the company's strong Q4 revenue ...

Globus Medical GMED continues to gain from surging demand for its Musculoskeletal Solutions products. However, a challenging ...

BofA analyst Craig Bijou upgraded Globus Medical (GMED) to Neutral from Underperform with a price target of $97, up from $80, ...

Globus Power Generation Limited in the name of Globus Constructors and Developers Limited was incorporated on June 19th 1985. The Company is engaged in businesses of making strategic investments in ...

Globus said it will offer 33 unique itineraries to Italy in 2025, covering 13 regions, 99 cities and several travel styles.

No Name of the Company Secretary: Kamini Designation: Compliance Officer EmailId: [email protected] Name of the Chief Financial Officer: Alok Kumar Gupta Designation: CFO EmailId: [email protected] ...